Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 301,000 | 371,000 | 309,000 | 337,000 | 341,000 |
| General And Administrative Expense | 301,000 | 371,000 | 309,000 | 337,000 | 341,000 |
| Depreciation And Amortization In Income Statement | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 |
| Operating Expense | 304,000 | 374,000 | 312,000 | 340,000 | 344,000 |
| Operating Income | -304,000 | -374,000 | -312,000 | -340,000 | -344,000 |
| EBIT | -494,000 | 523,000 | -551,000 | -382,000 | -254,000 |
| Interest Expense | 15,000 | 12,000 | 13,000 | 10,000 | 13,000 |
| Interest Expense Non Operating | 15,000 | 12,000 | 13,000 | 10,000 | 13,000 |
| Interest Income | 8,000 | 8,000 | 6,000 | 8,000 | 12,000 |
| Interest Income Non Operating | 8,000 | 8,000 | 6,000 | 8,000 | 12,000 |
| Net Interest Income | -7,000 | -4,000 | -7,000 | -2,000 | -1,000 |
| Other Income Expense | -198,000 | 889,000 | -245,000 | -50,000 | 78,000 |
| Other Non Operating Income Expenses | 6,000 | 62,000 | -- | 199,000 | 8,000 |
| Special Income Charges | -204,000 | 827,000 | -245,000 | -249,000 | 70,000 |
| Pretax Income | -509,000 | 511,000 | -564,000 | -392,000 | -267,000 |
| Tax Effect Of Unusual Items | 0.00 | 124,050 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -509,000 | 511,000 | -564,000 | -392,000 | -267,000 |
| Net Income From Continuing Operation Net Minority Interest | -509,000 | 511,000 | -564,000 | -392,000 | -267,000 |
| Net Income Including Noncontrolling Interests | -509,000 | 511,000 | -564,000 | -392,000 | -267,000 |
| Net Income Common Stockholders | -509,000 | 511,000 | -564,000 | -392,000 | -267,000 |
| Net Income | -509,000 | 511,000 | -564,000 | -392,000 | -267,000 |
| EBITDA | -490,000 | 526,000 | -548,000 | -379,000 | -251,000 |
| Normalized EBITDA | -286,000 | -301,000 | -303,000 | -130,000 | -321,000 |
| Reconciled Depreciation | 4,000 | 3,000 | 3,000 | 3,000 | 3,000 |
| Basic EPS | -0.01 | 0.01 | -0.01 | -- | -0.01 |
| Diluted EPS | -0.01 | 0.01 | -0.01 | -- | -0.01 |
| Basic Average Shares | 53.3M | 53.3M | 53.3M | -- | 53.3M |
| Diluted Average Shares | 53.3M | 54.2M | 53.3M | -- | 53.3M |
| Total Unusual Items | -204,000 | 827,000 | -245,000 | -249,000 | 70,000 |
| Total Unusual Items Excluding Goodwill | -204,000 | 827,000 | -245,000 | -249,000 | 70,000 |
| Tax Rate For Calcs | 0.00 | 0.15 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -305,000 | -191,950 | -319,000 | -143,000 | -337,000 |
| Depreciation Amortization Depletion Income Statement | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 |
| Depreciation Income Statement | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 |
| Diluted NI Availto Com Stockholders | -509,000 | 511,000 | -564,000 | -392,000 | -267,000 |
| Gain On Sale Of Ppe | 0.00 | 988,000 | -- | 0.00 | 261,000 |
| Impairment Of Capital Assets | 204,000 | 161,000 | 245,000 | 249,000 | 191,000 |
| Net Income Continuous Operations | -509,000 | 511,000 | -564,000 | -392,000 | -267,000 |
| Net Non Operating Interest Income Expense | -7,000 | -4,000 | -7,000 | -2,000 | -1,000 |
| Other Gand A | 289,000 | 367,000 | 304,000 | 64,000 | 330,000 |
| Salaries And Wages | 12,000 | 4,000 | 5,000 | 273,000 | 11,000 |
| Total Expenses | 304,000 | 374,000 | 312,000 | 340,000 | 344,000 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 605,000 | 1.1M | 498,000 | 870,000 | 1.0M |
| Cash Cash Equivalents And Short Term Investments | 605,000 | 1.1M | 498,000 | 870,000 | 1.0M |
| Accounts Receivable | 69,000 | 76,000 | 74,000 | 61,000 | 76,000 |
| Receivables | 69,000 | 76,000 | 74,000 | 61,000 | 76,000 |
| Prepaid Assets | 401,000 | 433,000 | 472,000 | 294,000 | 437,000 |
| Current Assets | 1.1M | 1.6M | 1.5M | 1.2M | 1.5M |
| Gross PPE | 76.2M | 76.0M | 75.8M | 76.0M | 75.7M |
| Accumulated Depreciation | -71.3M | -71.1M | -71.0M | -70.7M | -70.5M |
| Net PPE | 4.8M | 4.8M | 4.9M | 5.3M | 5.3M |
| Goodwill And Other Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non Current Assets | 375,000 | 375,000 | 375,000 | 375,000 | 375,000 |
| Total Non Current Assets | 5.2M | 5.2M | 5.2M | 5.7M | 5.7M |
| Total Assets | 6.3M | 6.8M | 6.7M | 6.9M | 7.2M |
| Accounts Payable | 451,000 | 682,000 | 1.1M | 721,000 | 655,000 |
| Payables | 682,000 | 682,000 | 1.1M | 721,000 | 655,000 |
| Payables And Accrued Expenses | 682,000 | 682,000 | 1.1M | 721,000 | 655,000 |
| Other Current Liabilities | 1.6M | 1.6M | 1.6M | -- | -- |
| Current Liabilities | 2.3M | 2.2M | 2.7M | 721,000 | 655,000 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 1.3M | 1.3M |
| Total Liabilities Net Minority Interest | 2.3M | 2.2M | 2.7M | 2.0M | 1.9M |
| Common Stock | 136.0M | 136.0M | 136.0M | 136.0M | 136.0M |
| Capital Stock | 136.0M | 136.0M | 136.0M | 136.0M | 136.0M |
| Additional Paid In Capital | 9.8M | 9.8M | 9.8M | 9.8M | 9.8M |
| Retained Earnings | -141.7M | -141.2M | -141.7M | -140.9M | -140.5M |
| Common Stock Equity | 4.0M | 4.5M | 4.0M | 4.9M | 5.2M |
| Stockholders Equity | 4.0M | 4.5M | 4.0M | 4.9M | 5.2M |
| Total Equity Gross Minority Interest | 4.0M | 4.5M | 4.0M | 4.9M | 5.2M |
| Total Capitalization | 4.0M | 4.5M | 4.0M | 4.9M | 5.2M |
| Net Tangible Assets | 4.0M | 4.5M | 4.0M | 4.9M | 5.2M |
| Tangible Book Value | 4.0M | 4.5M | 4.0M | 4.9M | 5.2M |
| Working Capital | -1.2M | -685,000 | -1.2M | 504,000 | 882,000 |
| Invested Capital | 4.0M | 4.5M | 4.0M | 4.9M | 5.2M |
| Share Issued | 53.3M | 53.3M | 53.3M | 53.3M | 53.3M |
| Ordinary Shares Number | 53.3M | 53.3M | 53.3M | 53.3M | 53.3M |
| Assets Held For Sale Current | -- | -- | 420,000 | -- | -- |
| Construction In Progress | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M |
| Current Provisions | -- | -- | 1.6M | -- | -- |
| Long Term Provisions | -- | -- | -- | 1.3M | 1.3M |
| Other Payable | 231,000 | -- | -- | -- | -- |
| Other Properties | 1.7M | 1.7M | 1.7M | 1.7M | 1.7M |
| Properties | 54.5M | 54.3M | 54.1M | 54.3M | 54.1M |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -243,000 | -669,000 | -150,000 | 95,000 | -210,000 |
| Cash Flow From Continuing Operating Activities | -243,000 | -669,000 | -150,000 | 95,000 | -210,000 |
| Depreciation And Amortization | 4,000 | 3,000 | 3,000 | 3,000 | 3,000 |
| Depreciation Amortization Depletion | 4,000 | 3,000 | 3,000 | 3,000 | 3,000 |
| Stock Based Compensation | 11,000 | 4,000 | 5,000 | 9,000 | 11,000 |
| Change In Working Capital | -198,000 | -338,000 | 149,000 | 225,000 | 100,000 |
| Change In Receivables | 1,000 | 1,000 | -12,000 | 16,000 | -3,000 |
| Change In Payables And Accrued Expense | -231,000 | -378,000 | 339,000 | 66,000 | 46,000 |
| Change In Payable | -231,000 | -378,000 | 339,000 | 66,000 | 46,000 |
| Other Non Cash Items | 231,000 | -27,000 | 7,000 | -6,000 | -9,000 |
| Capital Expenditure | -205,000 | -184,000 | -222,000 | -249,000 | -191,000 |
| Purchase Of PPE | -205,000 | -184,000 | -222,000 | -249,000 | -191,000 |
| Net PPE Purchase And Sale | -205,000 | 1.2M | -222,000 | -249,000 | 70,000 |
| Investing Cash Flow | -205,000 | 1.2M | -222,000 | -249,000 | 70,000 |
| Cash Flow From Continuing Investing Activities | -205,000 | 1.2M | -222,000 | -249,000 | 70,000 |
| Effect Of Exchange Rate Changes | -- | -- | -- | 0.00 | 0.00 |
| Changes In Cash | -448,000 | 555,000 | -372,000 | -154,000 | -140,000 |
| Beginning Cash Position | 1.1M | 498,000 | 870,000 | 1.0M | 1.2M |
| End Cash Position | 605,000 | 1.1M | 498,000 | 870,000 | 1.0M |
| Free Cash Flow | -448,000 | -853,000 | -372,000 | -154,000 | -401,000 |
| Asset Impairment Charge | 205,000 | 161,000 | 245,000 | 249,000 | 191,000 |
| Change In Prepaid Assets | 32,000 | 39,000 | -178,000 | 143,000 | 57,000 |
| Depreciation | 4,000 | 3,000 | 3,000 | 3,000 | 3,000 |
| Gain Loss On Sale Of PPE | 0.00 | -- | -- | 0.00 | -261,000 |
| Interest Received Cfo | 14,000 | 5,000 | 5,000 | 7,000 | 21,000 |
| Net Income From Continuing Operations | -510,000 | 511,000 | -564,000 | -392,000 | -266,000 |
| Operating Gains Losses | 0.00 | -- | -- | 0.00 | -- |
| Sale Of PPE | 0.00 | -- | -- | 0.00 | 261,000 |